Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
A 3.5 angstrom resolution electron density map of the HIV-1 reverse transcriptase heterodimer complexed with nevirapine, a drug with potential for treatment of AIDS, reveals an asymmetric dimer. The polymerase (pol) domain of the 66-kilodalton subunit has a large cleft analogous to that of the Klenow fragment of Escherichia coli DNA polymerase I. However, the 51-kilodalton subunit of identical sequence has no such cleft because the four subdomains of the pol domain occupy completely different relative positions. Two of the four pol subdomains appear to be structurally related to subdomains of the Klenow fragment, including one containing the catalytic site. The subdomain that appears likely to bind the template strand at the pol active site has a different structure in the two polymerases. Duplex A-form RNA-DNA hybrid can be model-built into the cleft that runs between the ribonuclease H and pol active sites. Nevirapine is almost completely buried in a pocket near but not overlapping with the pol active site. Residues whose mutation results in drug resistance have been approximately located.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the connection domain lacks any catalytic site and has α–helices on only one side of the β–sheet (Figure 2a), compared to the RNH and IN domains (Figure 2b and 2c, respectively) [14].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“The mature, functional form of HIV-1 RT is a heterodimer, comprising 66 kDa and 51 kDa subunits (Figure 1b)”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“the connection domain directly interacts with nucleic acids via positively charged side chains to help heterodimer formation and possibly position the substrate in the RNH active site [14,15].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
Citations
Cites
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Self-citationResolution of phase ambiguity in macromolecular crystallography
Wang, B.-C. (1985) · Methods in Enzymology · doi:10.1016/0076-6879(85)15009-3 · Cited by 1,028
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Fidelity of HIV-1 reverse transcriptase
Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988) · Science · doi:10.1126/science.2460924 · Cited by 931
Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP
Ollis, D. L., Brick, P., Hamlin, R., Xuong, N. G., & Steitz, T. A. (1985) · Nature · doi:10.1038/313762a0 · Cited by 848
Self-citationWeiss, R. A., & Bernstein, A. (1982) · Cold Spring Harbor Laboratory eBooks · Cited by 828
Carson, M. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891007240 · Cited by 808
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Research works printed but not linked: 2
- Kohlstaedt, L. A., Proceedings of the National Academy of Sciences of the United States of America 89: 9652 (1992).
- VARMUS, H, REVERSE TRANSCRIPTION, SCIENTIFIC AMERICAN 257: 56 (1987).
Cited by
Items 301–400 of 1,005
Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
Maeda, K., Das, D., Kobayakawa, T., Tamamura, H., & Takeuchi, H. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190712204603 · Cited by 126
Menéndez‐Arias, L. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)71042-8 · Cited by 120
Pauwels, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.07.005 · Cited by 104
Characterization of an African Swine Fever Virus 20-kDa DNA Polymerase Involved in DNA Repair
Oliveros, M., Yáñez, R. J., Salas, M. L., Salas, J., Viñuela, E., & Blanco, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30899 · Cited by 103
Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors
Asahchop, E. L., Wainberg, M. A., Sloan, R. D., & Tremblay, C. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00591-12 · Cited by 102
“The NNRTI binding pocket is located largely in the p66 subunit of RT and consists of the following residues: 95, 100, 101, 103, 106, 108, 179, 181, 188, 190, 227, 229, 234, 236, and 318 (36, 73).”
Boyer, P. L., & Hughes, S. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1624 · Cited by 113
“The Met-184 residue is part of the YXDD motif, which contains two of the three aspartic acid residues that compose the RT polymerase active site (23, 24, 31, 36).”
BackgroundNermut, M. V., & Fassati, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8196-8206.2003 · Cited by 130
“The actual process of reverse transcription is fairly well understood (for details, see reference 43 and Fig. 7). It is catalyzed by reverse transcriptase (RT), a DNA polymerase that can employ both RNA and DNA as a template and whose crystal structure has been solved (25, 27 , 43).”
BackgroundTachedjian, G., Orlova, M., Sarafianos, S. G., Arnold, E., & Goff, S. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121055998 · Cited by 110
Arya, D. P., Coffee, R. L., Willis, B., & Abramovitch, A. I. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003052x · Cited by 103
Beard, W. A., Stahl, S. J., Kim, H., Bębenek, K., Kumar, A., Strub, M., Becerra, S. P., Kunkel, T. A., & Wilson, S. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46899-8 · Cited by 114
Coordination compounds in medicinal chemistry
Schwietert, C. W., & McCue, J. P. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00205-7 · Cited by 130
Nijhuis, M., Schuurman, R., de Jong, D. C. M., van Leeuwen, R., Lange, J. M. A., Danner, S. A., Keulen, W., de Groot, T. M., & Boucher, C. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/514056 · Cited by 105
Wang, H., & Lambowitz, A. M. (1993) · Cell · doi:10.1016/0092-8674(93)90317-j · Cited by 111
Human DNA polymerases alpha and beta are able to incorporate anti-HIV deoxynucleotides into DNA.
Copeland, W. C., Chen, M. S., & Wang, T. S. ‐. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36631-1 · Cited by 100
pH-Induced Activation of Arenavirus Membrane Fusion Is Antagonized by Small-Molecule Inhibitors
York, J., Dai, D., Amberg, S. M., & Nunberg, J. H. (2008) · Journal of Virology · doi:10.1128/jvi.01140-08 · Cited by 101
“As with the chemically diverse nonnucleoside analog inhibitors of human immunodeficiency virus type 1 reverse transcriptase, all of which bind a common hydrophobic pocket (12, 31, 44), it is possible that the bound forms of the SIGA inhibitors share spatial and chemical characteristics.”
BackgroundHuang, W., Gamarnik, A. V., Limoli, K. L., Petropoulos, C. J., & Whitcomb, J. M. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1512-1523.2003 · Cited by 101
“Although structurally diverse, all NNRTI drugs inhibit HIV-1 reverse transcriptase (RT) by binding to a hydrophobic pocket adjacent to the active site (21, 43, 45).”
BackgroundThe structure of HIV‐1 reverse transcriptase complexed with an RNA pseudoknot inhibitor
Jäger, J., Restle, T., & Steitz, T. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4535 · Cited by 112
“The relative orientation of the p66 polymerase domain with respect to the RNase H and p51 thumb domains corresponds to that observed in the orthorhombic crystal form of a Nevirapine complex (Jaeger et al., 1994) and in the apo-enzyme (Rodgers et al., 1995).”
BackgroundInfluentialSelf-citationPichoud, C., Seignères, B., Wang, Z., TREPO, C. G., & Zoulim, F. (1999) · Hepatology · doi:10.1002/hep.510290119 · Cited by 101
Recognition of the Rotavirus mRNA 3′ Consensus by an Asymmetric NSP3 Homodimer
Deo, R. C., Groft, C. M., Rajashankar, K. R., & Burley, S. K. (2002) · Cell · doi:10.1016/s0092-8674(01)00632-8 · Cited by 111
Maga, G., Amacker, M., Ruel, N., Hübscher, U., & Spadari, S. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1427 · Cited by 106
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
Das, K., & Arnold, E. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.014 · Cited by 100
Corte, B. L. D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040127p · Cited by 99
Burke, D. H., Scates, L., Andrews, K., & Gold, L. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0667 · Cited by 105
“The details of the protein structure and of the interactions at the protein-substrate interface have also been explored through crystallographic analysis (Arnold et al., 1995; Jacobo-Molina et al., 1993; Jager et al., 1994; Kohlstaedt et al., 1992; Setlik et al., 1994; Unge et al., 1994).”
BackgroundArcher, R. H., Dykes, C., Gerondelis, P., Lloyd, A., Fay, P., Reichman, R. C., Bambara, R. A., & Demeter, L. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8390-8401.2000 · Cited by 99
“NNRTIs inhibit HIV-1 RT by binding a specific region of the p66 subunit of RT that is adjacent to the polymerase active site of the enzyme (13, 39, 55).”
BackgroundInfluentialGu, Z., Fletcher, R. S., Arts, E. J., Wainberg, M. A., & Parniak, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46902-5 · Cited by 99
Jones, S. A., & Hu, J. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.56 · Cited by 104
Arts, E. J., Ghosh, M., Jacques, P. S., Ehresmann, B., & Grice, S. F. J. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.9054 · Cited by 98
Zoulim, F., & TREPO, C. G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80191-8 · Cited by 105
Yang, X., Smidansky, E. D., Maksimchuk, K. R., Lum, D., Welch, J. L., Arnold, J. J., Cameron, C. E., & Boehr, D. D. (2012) · Structure · doi:10.1016/j.str.2012.06.012 · Cited by 102
“The catalytic site, in the so-called palm subdomain, of RdRps and RTs superimposes quite well with A- and B-family polymerases (Hansen et al., 1997; Kohlstaedt et al., 1992; Singh and Modak, 1998).”
BackgroundNabatov, A. A., Pollakis, G., Linnemann, T., Kliphius, A., Chalaby, M. I. M., & Paxton, W. A. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.524-530.2004 · Cited by 115
Qin, W., Luo, H., Nomura, T., Hayashi, N., Yamashita, T., & Murakami, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106880200 · Cited by 97
RetractedSharma, P., & Crumpacker, C. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8846-8851.1997 · Cited by 103
“The studies on HIV-1 RT crystal structures have shown the significant positioning of RT codon 74 on the b4 strand of the finger domain in the formation of the template grip that consists of portions of the p66 palm and fingers (2, 18, 21).”
BackgroundSismour, A. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh241 · Cited by 96
“This represents a more delicate modification of the structure than would be had by directed mutation in the active site itself (17, 18 ).”
BackgroundTelesnitsky, A., & Goff, S. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1276 · Cited by 95
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
Whitcomb, J. M., Huang, W., Limoli, K. L., Paxinos, E. E., Wrin, T., Skowron, G., Deeks, S. G., Bates, M. P., Hellmann, N. S., & Petropoulos, C. J. (2002) · AIDS · doi:10.1097/00002030-200210180-00002 · Cited by 96
“[3] and it is believed that NNRTI inhibit HIV-1 RT by distorting the normal structural conformation of the enzyme [4,5].”
BackgroundSu, H.-P., Yan, Y., Prasad, G. S., Smith, R. F., Daniels, C. L., Abeywickrema, P. D., Reid, J. C., Loughran, H. M., Kornienko, M., Sharma, S., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00353-10 · Cited by 94
“This condition requires cocrystallization with an NNRTI, such as nevirapine (19).”
BackgroundBerkhout, B., & Hemert, F. J. V. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.9.1705 · Cited by 95
HIV-1 reverse transcriptase inhibitors
Safadi, Y. E., Vivet‐Boudou, V., & Marquet, R. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0919-7 · Cited by 110
“They are not incorporated into nascent viral DNA, are noncompetitive inhibitors, and bind into a hydrophobic “pocket” in the p66 subunit of HIV-1 RT located close to (but distinct from) the NRTI binding site (Kohlstaedt et al. 1992; Pata et al. 2004).”
BackgroundHIV Protease as an Inhibitor Target for the Treatment of AIDS
Darke, P. L., & Huff, J. R. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60438-x · Cited by 95
Dose–response curve slope is a missing dimension in the analysis of HIV-1 drug resistance
Sampah, M. E. S., Shen, L., Jilek, B. L., & Siliciano, R. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018360108 · Cited by 92
Zeevaart, J. G., Wang, L., Thakur, V. V., Leung, C. S., Tirado-Rives, J., Bailey, C. M., Domaoal, R. A., Anderson, K. S., & Jorgensen, W. L. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8019214 · Cited by 93
Dawn of non-nucleoside inhibitor-based anti-HIV microbicides
D’Cruz, O. J., & Uckun, F. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki464 · Cited by 93
The phage RNA polymerases are related to DNA polymerases and reverse transcriptases
McAllister, W. T., & Raskin, C. A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00897.x · Cited by 92
Nucleoside and nucleotide inhibitors of HIV-1 replication
Vivet‐Boudou, V., Didierjean, J., Isel, C., & Marquet, R. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5367-x · Cited by 106
Christensen, S. M., & Eickbush, T. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6617-6628.2005 · Cited by 90
“from the human immunodeficiency virus, which appears to function as a dimer (18).”
BackgroundEmtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus
Saravolatz, L. D., & Saag, M. S. (2005) · Clinical Infectious Diseases · doi:10.1086/498348 · Cited by 91
Beerens, N., & Berkhout, B. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2329-2339.2002 · Cited by 91
“The RNase H domain of HIV-1 RT is located 18 nt from the polymerase active site (24, 26).”
BackgroundElder, J. H., Schnölzer, M., Hasselkus-Light, C. S., Henson, M., Lerner, D. A., Phillips, T. R., Wagaman, P. C., & Kent, S. B. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1869-1876.1993 · Cited by 91
“The feline enzyme can now be modeled on the detailed structures recently established for HIV RT (2, 17) as a prelude to development of generalized inhibitors of RT and possibly of RNase H.”
BackgroundCaliendo, A. M., Savara, A. V., An, D., Devore, K. M., Kaplan, J. C., & D’Aquila, R. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2146-2153.1996 · Cited by 102
“In structural models of RT, amino acid residues 67, 70, and 215 as well as 74 are in close proximity to the RNA template (20, 27, 52).”
BackgroundPillay, D., Walker, A. S., Gibb, D. M., Rossi, A. D., Kaye, S., Ait‐Khaled, M., Muñoz‐Fernández, M. Á., Babiker, A. G., & Paediatric European Network for Treatment of AIDS (PENTA) (2002) · The Journal of Infectious Diseases · doi:10.1086/342680 · Cited by 103
Antoni, A. D., Foli, A., Lisziewicz, J., & Lori, F. (1997) · The Journal of Infectious Diseases · doi:10.1086/516511 · Cited by 91
“It is known that nucleoside analogues bind to a hydrophobic pocket close to the active site in the p66 subdomain [27].”
BackgroundBibiłło, A., & Eickbush, T. H. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5369 · Cited by 97
Barreiro, G., Guimarães, C. R. W., Tubert‐Brohman, I., Lyons, T. M., Tirado‐Rives, J., & Jorgensen, W. L. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700271z · Cited by 90
Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase
BLOCKER, F. J. H., MOHR, G., CONLAN, L. H., QI, L., BELFORT, M., & LAMBOWITZ, A. M. (2005) · RNA · doi:10.1261/rna.7181105 · Cited by 90
“The HIV-1 RT, for which X-ray crystal structures have been determined, is a heterodimer consisting of a p66 subunit, comprised of fingers, palm, thumb, connection, and RNase H domains, and a p51 subunit, which is derived from p66 by a proteolytic cleavage that removes the RNase H domain (Kohlstaedt et al. 1992).”
BackgroundCrystal engineering of HIV-1 reverse transcriptase for structure-based drug design
Bauman, J. D., Das, K., Ho, W. C., Baweja, M., Himmel, D. M., Clark, A. D., Oren, D. A., Boyer, P. L., Hughes, S. H., Shatkin, A. J., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn464 · Cited by 88
Nonnucleoside Reverse Transcriptase Inhibitor Resistance
Deeks, S. G. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200103011-00004 · Cited by 90
Ivetac, A., & McCammon, J. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.037 · Cited by 89
Isolation of RNase H Genes That Are Essential for Growth of Bacillus subtilis 168
Itaya, M., Omori, A., Kanaya, S., Crouch, R. J., Tanaka, T., & Kondo, K. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2118-2123.1999 · Cited by 89
“coli RNase HI (25, 41), it may require an additional polypeptide for RNase H activity, similar to that observed for RNase H of HIV reverse transcriptase (28).”
BackgroundMethodDemeter, L. M., Shafer, R. W., Meehan, P. M., Holden‐Wiltse, J., Fischl, M. A., Freimuth, W. W., Para, M. F., & Reichman, R. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.794-797.2000 · Cited by 89
“(%)] Caucasian 61 (73) 18 (90) 7 (78) 3 (60) African-American 15 (18) 2 (10) 1 (11) 1 (20) Hispanic 8 (10) 0 (0) 1 (11) 1 (20) ZDV naive [no.”
BackgroundWakefield, J., Jablonski, S. A., & Morrow, C. D. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6806-6812.1992 · Cited by 89
“promote a phosphoryl transfer reaction (6, 26).”
BackgroundHIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88
“the non-nucleoside binding pocket, a hydrophobic depression created by the binding of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and located near the base of the p66 thumb subdomain, about 10 Å from the polymerase active site [4,64,65].”
BackgroundHizi, A., Tal, R., Shaharabany, M., Currens, M. J., Boyd, M. R., Hughes, S. H., & McMahon, J. B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1037 · Cited by 88
“The importance of tyrosines 181 and 188 to the binding of these nonnucleoside analogs was further supported by mapping those portions of the RT molecule that are bound covalently to a labeled nevirapine analog (9) and by the three-dimensional structure of HIV-1 RT bound to nevirapine (22).”
BackgroundInfluentialGu, Z., Quan, Y., Zhou, L., Arts, E. J., & Wainberg, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31046 · Cited by 88
LOCARNINI, S. A. (1998) · Hepatology · doi:10.1002/hep.510270144 · Cited by 88
Jonckheere, H., Taymans, J., Balzarini, J. M., Velázquez, S., Camarasa, M., Desmyter, J., Clercq, E. D., & Anné, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47240-7 · Cited by 95
Wing, R. A., Bailey, S., & Steitz, T. A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.058 · Cited by 90
Self-citationAnti-HIV activity of aromatic and heterocyclic Thiazolyl Thiourea compounds
Venkatachalam, T. K., Sudbeck, E. A., Mao, C., & Uckun, F. M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00011-7 · Cited by 87
Distribution and Phylogeny of Penelope-Like Elements in Eukaryotes
Arkhipova, I. R. (2006) · Systematic Biology · doi:10.1080/10635150601077683 · Cited by 87
“A secondary structure prediction for the region immediately downstream of the seven core RT domains consistently shows three conserved a-helices, a structure typical of the thumb domain of retroviral and group II intron RTs (Kohlstaedt et al., 1992; Blocker et al., 2005).”
BackgroundA Mutant of Tetrahymena Telomerase Reverse Transcriptase with Increased Processivity
Bryan, T. M., Goodrich, K. J., & Cech, T. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003246200 · Cited by 100
(1993) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a039990 · Cited by 87
“Amino acid residues in the “thumb subdomain” of the reverse transcriptase (Kohlstaedt et al. 1992) and in the nucleic acidbinding domain that are found in seven of the eight RI sequences are indicated below the RlPj3 sequence.”
BackgroundInfluentialInteraction of Retroviral Reverse Transcriptase with Template–Primer Duplexes during Replication
Arts, E. J., & Grice, S. F. J. L. (1997) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60041-0 · Cited by 92
Gerondelis, P., Archer, R. H., Palaniappan, C., Reichman, R. C., Fay, P. J., Bambara, R. A., & Demeter, L. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5803-5813.1999 · Cited by 86
“The NNRTIs are noncompetitive inhibitors that bind to a hydrophobic pocket adjacent to the polymerase active site of RT (16, 23, 31, 47).”
BackgroundPowell, M. D., & Levin, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5288-5296.1996 · Cited by 86
Götte, M., Fackler, S., Hermann, T., Perola, E., Cellai, L., Gross, H. J., Grice, S. F. L., & Heumann, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07061.x · Cited by 89
Role of histidine 124 in the catalytic function of ribonuclease HI from Escherichia coli
Oda, Y., Yoshida, M., & Kanaya, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54118-1 · Cited by 85
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
Singh, K., Marchand, B., Kirby, K. A., Michailidis, E., & Sarafianos, S. G. (2010) · Viruses · doi:10.3390/v2020606 · Cited by 99
“The region that connects the RT thumb subdomain to the RNase H subdomain (residues 427–560) was called connection subdomain (residues 319–426) [12,17,20].”
BackgroundInfluentialLim, S. E., Ponamarev, M. V., Longley, M. J., & Copeland, W. C. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00405-4 · Cited by 89
Brehm, J. H., Koontz, D., Meteer, J. D., Pathak, V., Sluis-Cremer, N., & Mellors, J. W. (2007) · Journal of Virology · doi:10.1128/jvi.02203-06 · Cited by 85
“HIV-1 RT is a heterodimer composed of a 560-amino-acid, 66-kDa subunit (p66) and a p66-derived 440amino-acid, 51- kDa subunit (p51) (12, 16).”
BackgroundAction of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors
Imamichi, T. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382440 · Cited by 100
Kleim, J. P., Bender, R., Kirsch, R., Meichsner, C., Paessens, A., Rösner, M., Rübsamen‐Waigmann, H., Kaiser, R., Wichers, M., & Schneweis, K. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2253 · Cited by 88
“Belonging to different chemical classes, including tetrahydroimidazo (4,5,1jk)(1,4)-benzodiazepin-2(1H)-one and -thione (TIBO), dipyridodiazepinone, pyridinone, bis(heteroaryl)piperazine, and aanilinophenylacetamide derivatives (10, 21, 24, 25, 32), all NNRTIs are believed to bind to a lipophilic pocket within the p66…”
BackgroundJablonski, S. A., & Morrow, C. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1532-1539.1995 · Cited by 85
Dlakić, M., & Mushegian, A. (2011) · RNA · doi:10.1261/rna.2396011 · Cited by 84
(1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.5.345 · Cited by 84
Specific RNA Residue Interactions Required for Enzymatic Functions of Tetrahymena Telomerase
Gilley, D., & Blackburn, E. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.66 · Cited by 84
“The three-dimensional structures of three polymerases—Escherichia coli DNA-dependent DNA polymerase I, human immunodeficiency virus type 1 RNA-dependent reverse transcriptase, and T7 DNA-dependent RNA polymerase—all show remarkable similarities in their catalytic-site structures, involving a conserved set of catalytic…”
BackgroundProximity versus allostery: the role of regulated protein dimerization in biology
Austin, D. J., Schreiber, S. L., & Crabtree, G. R. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90002-7 · Cited by 87
The fastest genome evolution ever described: HIV variation in situ
Wain–Hobson, S. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90008-d · Cited by 99
Minnick, D. T., Astatke, M., Joyce, C. M., & Kunkel, T. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24954 · Cited by 84
“The x-ray crystal structures of HIV-1 reverse transcriptase (Kohlstaedt et al., 1992; JacoboMolina et al., 1993; for a review, see Arnold et al., 1995), T7 RNA polymerase (Sousa et al., 1993), human DNA polymerase b (Pelletier et al., 1994; Sawaya et al., 1994; Davies et al., 1994) and Thermus…”
BackgroundRaper, A. T., Reed, A. J., & Suo, Z. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00685 · Cited by 83
Crystal Structure of the Targeting Endonuclease of the Human LINE-1 Retrotransposon
Weichenrieder, O., Repanas, K., & Perrakis, A. (2004) · Structure · doi:10.1016/j.str.2004.04.011 · Cited by 100
Yang, Y., Kang, D., Nguyen, L. A., Smithline, Z. B., Pannecouque, C. C., Zhan, P., Liu, X., & Steitz, T. A. (2018) · eLife · doi:10.7554/elife.36340 · Cited by 84
Self-citationKleim, J. P., Rösner, M., Winkler, I., Paessens, A., Kirsch, R., Hsiou, Y., Arnold, E., & Riess, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.34 · Cited by 90
Kavlick, M. F., Shirasaka, T., Kojima, E., Pluda, J. M., Hui, F. K., Yarchoan, R., & Mitsuya, H. (1995) · Antiviral Research · doi:10.1016/0166-3542(95)00044-m · Cited by 86
HIV-1 inactivation by nucleic acid aptamers
Daniel, M. H. (2006) · Frontiers in bioscience · doi:10.2741/1782 · Cited by 96
“This can be understood from an examination of crystal structures of RT-drug and RT-substrate complexes wherein resistance mutations map closely together in the three-dimensional structure (50, 64-67).”
BackgroundPata, J. D., Stirtan, W. G., Goldstein, S. W., & Steitz, T. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404151101 · Cited by 97
Self-citationNuclear functions of NME proteins
Puts, G. S., Leonard, M. K., Pamidimukkala, N., Snyder, D. E., & Kaetzel, D. M. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.109 · Cited by 82
Structure and function of DNA-binding proteins
Nelson, H. C. M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80006-9 · Cited by 98
Suzuki, M., Baskin, D. S., Hood, L., & Loeb, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9670 · Cited by 82
Ludovici, D. W., Kukla, M. J., Grous, P. G., Krishnan, S. M., Andries, K., de Béthune, M., Azijn, H., Pauwels, R., Clercq, E. D., Arnold, E., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00410-3 · Cited by 82
Human Immunodeficiency Virus Type-1 Reverse Transcriptase
Wilson, J. E., AULABAUGH, A. E., Caligan, B., McPherson, S. A., Wakefield, J., Jablonski, S. A., Morrow, C. D., Reardon, J. E., & Furman, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13656 · Cited by 86
Schultz, P., Celia, H., Riva, M., Sentenac, A., & Oudet, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05920.x · Cited by 82
Metadata
- Authors
- Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1992-06-26
- Volume
- 256
- Issue
- 5065
- Pages
- 1783-1790
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2008954911
- Cited by
- 1,914
- References
- 67
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 29 · 2020: 18 · 2019: 24 · 2018: 37 · 2017: 39 · 2016: 39 · 2015: 38 · 2014: 44 · 2013: 63 · 2012: 42
- FWCI
- 128.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01gm039546-10)
- National Institute of General Medical Sciences (GM 39546)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 reverse transcriptase, nevirapine, drug resistance, polymerase domain, asymmetric dimer, RNase H, RNA-DNA hybrids, active site, protein-inhibitor complex
- MeSH terms
- Azepines, Binding Sites, Crystallography, DNA Polymerase I, Escherichia coli, Models, Molecular, Protein Conformation, Pyridines, RNA-Directed DNA Polymerase, Molecular Structure, HIV-1, Nevirapine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.